US biotech investor Celtic Therapeutics gets $100m commitment, partnership from PPD | AltAssets Private Equity News

Subscribe today

Advanced
Search

US biotech investor Celtic Therapeutics gets $100m commitment, partnership from PPD

5 Nov 2009

Celtic Therapeutics, a US biotech investor, has seen Nasdaq-listed contract research organisation PPD Inc commit $100m for its investments in novel therapeutic product candidates.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.